Methods for treating or preventing acute respiratory distress syndrome
AssigneeCSL Innovation Pty Ltd
InventorsCatherine Mary OWCZAREK, Ian Keith CAMPBELL, Karolina KRSTEVSKI, Steven BOZINOVSKI, Angel Francisco LOPEZ, Damon John TUMES
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of treating or preventing acute respiratory distress syndrome (ARDS) using compounds that bind to CD131 and neutralize signaling by IL-3, IL-5 and GM-CSF. The present disclosure also relates to compounds for use in the treatment or prevention of ARDS, as well as the use of such compounds in the manufacture of medicaments for the treatment or prevention of ARDS.
Claims25
A method for preventing or treating acute respiratory syndrome (ARDS) in a subject, the method comprising administering a compound that binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5, and granulocyte-macrophage colony stimulating factor (GM-CSF) to the subject.
4-7. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.